Biotecon Diagnostics Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
M&A
Biotecon Diagnostics General Information
Description
Developer of polymerase chain reaction systems catering to the biotechnology industry. The company engages in the detection of genetically modified organisms and also focuses on the development, production and international marketing of real-time PCR-based rapid tests and standardized microbiological analysis, thereby enabling clients to produce food and beverages with advanced preservatives and keep it safe.
Contact Information
Website
www.bc-diagnostics.comCorporate Office
- Hermannswerder 17
- 14473 Potsdam
- Germany
Corporate Office
- Hermannswerder 17
- 14473 Potsdam
- Germany
Biotecon Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 24-Apr-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Sep-2000 | Completed | Startup |
Biotecon Diagnostics Comparisons
Industry
Financing
Details
Biotecon Diagnostics Competitors (19)
One of Biotecon Diagnostics’s 19 competitors is BGI Genomics, a Formerly VC-backed company based in Shenzhen, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| Exagen | Formerly VC-backed | Vista, CA | ||||
| R-Biopharm | Formerly PE-Backed | Darmstadt, Germany | ||||
| Enzo Biochem | Private Equity-Backed | Farmingdale, NY | ||||
| PerkinElmer | Private Equity-Backed | Shelton, CT |
Biotecon Diagnostics Patents
Biotecon Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102015012691-A1 | Method for the quantitative detection of vibrio parahaemolyticus, vibrio vulnificus and vibrio cholerae | Inactive | 28-Sep-2015 | ||
| EP-3015553-A1 | Stabilised reaction mixture | Inactive | 30-Oct-2014 | ||
| EP-2287332-A1 | Nucleic acids and methods for environmental monitoring | Active | 07-Aug-2009 | ||
| EP-2287332-B1 | Nucleic acids and methods for environmental monitoring | Active | 07-Aug-2009 | ||
| WO-2011015355-A2 | Nucleic acids and methods for environmental monitoring | Inactive | 07-Aug-2009 | C12Q1/689 |
Biotecon Diagnostics Signals
Biotecon Diagnostics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BLS Venture Capital | Venture Capital | Minority | ||
| Vestcorp | Fund of Funds | Minority |
Biotecon Diagnostics FAQs
-
When was Biotecon Diagnostics founded?
Biotecon Diagnostics was founded in 1998.
-
Where is Biotecon Diagnostics headquartered?
Biotecon Diagnostics is headquartered in Potsdam, Germany.
-
What is the size of Biotecon Diagnostics?
Biotecon Diagnostics has 50 total employees.
-
What industry is Biotecon Diagnostics in?
Biotecon Diagnostics’s primary industry is Laboratory Services (Healthcare).
-
Is Biotecon Diagnostics a private or public company?
Biotecon Diagnostics is a Private company.
-
What is Biotecon Diagnostics’s current revenue?
The current revenue for Biotecon Diagnostics is .
-
How much funding has Biotecon Diagnostics raised over time?
Biotecon Diagnostics has raised $8M.
-
Who are Biotecon Diagnostics’s investors?
BLS Venture Capital and Vestcorp have invested in Biotecon Diagnostics.
-
Who are Biotecon Diagnostics’s competitors?
BGI Genomics, Exagen, R-Biopharm, Enzo Biochem, and PerkinElmer are some of the 19 competitors of Biotecon Diagnostics.
-
When was Biotecon Diagnostics acquired?
Biotecon Diagnostics was acquired on 24-Apr-2020.
-
Who acquired Biotecon Diagnostics?
Biotecon Diagnostics was acquired by Biochek.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process